Results 1 to 10 of about 38,751 (131)

Optimizing naloxone distribution to prevent opioid overdose fatalities: results from piloting the Systems Analysis and Improvement Approach within syringe service programs [PDF]

BMC Health Services Research, 2023
Background Opioid overdose fatalities are preventable with timely administration of naloxone, an opioid antagonist, during an opioid overdose event. Syringe service programs have pioneered naloxone distribution for potential bystanders of opioid overdose.
Sheila V. Patel, Lynn D. Wenger, Alex H. Kral, Kenneth Sherr, Anjuli D. Wagner, Peter J. Davidson, Barrot H. Lambdin   +6 more
doaj   +2 more sources

Treatment experiences for skin and soft tissue infections among participants of syringe service programs in North Carolina [PDF]

Harm Reduction Journal, 2021
Introduction Bacterial and fungal infections, such as skin and soft tissue infections (SSTIs) and infective endocarditis (IE), are increasing among people who use drugs in the United States.
Mary C. Figgatt, Zach R. Salazar, Louise Vincent, Diannee Carden-Glenn, Kelly Link, Lauren Kestner, Tyler Yates, Asher Schranz, Elizabeth Joniak-Grant, Nabarun Dasgupta   +9 more
doaj   +2 more sources

How do contextual factors influence naloxone distribution from syringe service programs in the USA: a cross-sectional study [PDF]

Harm Reduction Journal, 2023
Background Naloxone is a medication that can quickly reverse an opioid overdose. Syringe service programs (SSPs) are community-based prevention programs that provide a range of evidence-based interventions in the USA, including naloxone distribution ...
Barrot H. Lambdin, Lynn Wenger, Ricky Bluthenthal, Tyler S. Bartholomew, Hansel E. Tookes, Paul LaKosky, Savannah O’Neill, Alex H. Kral   +7 more
doaj   +2 more sources

Racial disparities in use of syringe service programs in King County, WA: a comparison of two cross-sectional surveys [PDF]

Harm Reduction Journal, 2023
Background Syringe service programs (SSPs) provide tools to people who inject drugs (PWID) to prevent overdose, reduce the risk of HIV and HCV infection, and reduce injection frequency.
Katheryn Salow, Helen E. Jack, Joe Tinsley, Caleb J. Banta-Green, Susan Kingston, Matthew Iles-Shih, Judith I. Tsui, Sara Glick   +7 more
doaj   +2 more sources

Facilitators and barriers to monitoring and evaluation at syringe service programs [PDF]

Harm Reduction Journal
Background Syringe services programs (SSPs) provide harm reduction supplies and services to people who use drugs and are often required by funders or partners to collect data from program participants.
Elise Healy, Arianna Rubin Means, Kelly Knudtson, Noah Frank, Alexa Juarez, Stephanie Prohaska, Courtney McKnight, Don Des Jarlais, Alice Asher, Sara N. Glick   +9 more
doaj   +2 more sources

The effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study [PDF]

Harm Reduction Journal, 2023
Background Syringe service programs (SSPs) deliver critical harm reduction services to people who inject drugs (PWID). Some SSPs in New York State received enhanced funding to provide additional services to combat opioid overdose fatalities.
Mercy Ude, Czarina N. Behrends, Shea Kelly, Bruce R. Schackman, Allan Clear, Rebecca Goldberg, Kitty Gelberg, Shashi N. Kapadia   +7 more
doaj   +2 more sources

Systems analysis and improvement approach to improve naloxone distribution within syringe service programs: study protocol of a randomized controlled trial [PDF]

Implementation Science, 2023
Background More than half a million Americans died of an opioid-related overdose between 1999 and 2020, the majority occurring between 2015 and 2020. The opioid overdose mortality epidemic disproportionately impacts Black, Indigenous, and people of color
Christopher F. Akiba, Sheila V. Patel, Lynn D. Wenger, Antonio Morgan-Lopez, Gary A. Zarkin, Stephen Orme, Peter J. Davidson, Alex H. Kral, Barrot H. Lambdin   +8 more
doaj   +2 more sources

Enhancing drug checking services for supply monitoring: perspectives on implementation in syringe service programs in the USA [PDF]

Harm Reduction Journal
Background Shifts in the US drug supply, including the proliferation of synthetic opioids and emergence of xylazine, have contributed to the worsening toll of the overdose epidemic.
Kyle J. Moon, Heather D. Whitehead, Anne Trinh, Kathryn A. Hasenstab, Kathleen L. Hayes, Debra Stanley, Brittany Carter, Rick Barclay, Marya Lieberman, Saira Nawaz   +9 more
doaj   +2 more sources

Evaluation of a "one-stop shop" for integrated harm reduction and primary care for people who inject drugs. [PDF]

PLoS ONE
BackgroundPeople who inject drugs (PWID) experience high risk for HIV and HCV infection, which can be mitigated by harm reduction strategies, including syringe service programs (SSP).
Nadeen Ibrahim, Shaifer Jones, Katherine Rich, Lisandra Alvarez, Carolina Price, Natalie Kil, Frederick L Altice, Jaimie P Meyer   +7 more
doaj   +2 more sources

Community-based drug checking at syringe service programs in New York City observe an increasing prevalence of xylazine from 2021 through 2024 [PDF]

Harm Reduction Journal
Background Xylazine has emerged as a major component of the unregulated opioid supply in several jurisdictions across the United States. However, the extent of xylazine in local drug supplies is unknown.
Leonardo A. Dominguez Gomez, Yarelix Estrada, Jeffery Sauer, Izza Zaidi, Andrew J. Trinidad, Hannah Helmy, Alex Harocopos   +6 more
doaj   +2 more sources